Hypersensitive reaction to botulinum toxin type A following Covid19 mRNA vaccination
Objective: two cases of hypersensitivity reactions to botulinum toxin type A (BTA) following mRNA based COVID-19 vaccine Background: Botulinum toxin type A is widely used…Lack of immunogenicity of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present pooled data analyses of the immunogenicity of incobotulinumtoxinA (INCO) in pediatrics. Background: BotulinumtoxinA (BoNT-A) is used to treat several chronic pediatric conditions,…Can abdominal internal oblique muscle be a possible target for ultrasound-guided Botulinum toxin injection in patients with Parkinson’s Disease affected by axials problems? An ultrasound study of our case series.
Objective: to demostrate the abdominal internal oblique muscle hypertrophy with ultrasound in patients with Parkinson’s Disease (PD) affected by axial problems, as a possible target…‘A study of seven patients with Hemimasticatory spasm; barriers to treatment and outcomes of botulinum toxin’
Objective: To assess barriers to treatment and outcomes of botulinum toxin in patients treated for Hemimasticatory spasm Background: Hemimasticatory spasm (HMS) is a rare peripherally induced…Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders
Objective: The SIPEXI (Sialorrhea Pediatric Xeomin Investigation) study investigated efficacy and safety of intraglandular incobotulinumtoxinA (incoBoNT/A) injections in children/adolescents with sialorrhea associated with neurological disorders…Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up
Objective: Investigate the safety and efficacy of botulinum toxin type A in Parkinson´s disease and parkinsonism patients affected by sialorrhea Background: Sialorrhea is excessive salivation…Pregnancy Outcomes Following Exposure to OnabotulinumtoxinA Update – 29 Years of Safety Observation
Objective: The present study evaluated pregnancy outcomes following onabotulinumtoxinA exposure to provide a cumulative 29-year safety update. Background: A previous publication of pregnancy outcomes in…Therapeutic effect of OnabotulinumtoxinA in bilateral hemifacial spasm, trigeminal neuralgia and chronic migraine in El Salvador
Objective: To Evaluate the therapeutic and preventive effect of OnabotulinumtoxinA in the treatment of trigeminal neuralgia (TN) and chronic migraine (CM) in patients with bilateral…IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study
Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles into the…Refining Knowledge on the Treatment of Pisa Syndrome with Botulinum Toxin
Objective: To analyze the efficacy of botulinum toxin (BoNT) in cases of pisa syndrome (PS) associated with Parkinson's disease (PD) targeting paraspinal muscles ipsilateral to…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 12
- Next Page »